FDG PET Applications for Head and Neck Cancers - Part 1

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
410 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Jul 16, 2010

Dr. Robert S. Bridwell, medical advisor to IBA Molecular North America, Inc., as well as Founder and Chief Medical Officer of PETLinQ LLC is joined by Dr. Lale Kostakoglu, the Director of PET/CT Oncology and Research at Mount Sinai School of Medicine in New York in a Molecular Imaging Panel Discussion at the 2010 SNM Annual Meeting. They discuss the current FDG Positron Emission Tomography (PET) applications for Head and Neck Cancers based on scientific literature and current oncologic guidelines. Areas of focus include the use of FDG PET for staging, restaging and response to therapy. Dr. Bridwell and Dr. Kostakoglu both received reasonable compensation from IBA Molecular North America, Inc. for appearing as part of the panel.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more